NZ222876A - Intermediates of dopamine-beta-hydroxylase inhibitors - Google Patents

Intermediates of dopamine-beta-hydroxylase inhibitors

Info

Publication number
NZ222876A
NZ222876A NZ222876A NZ22287685A NZ222876A NZ 222876 A NZ222876 A NZ 222876A NZ 222876 A NZ222876 A NZ 222876A NZ 22287685 A NZ22287685 A NZ 22287685A NZ 222876 A NZ222876 A NZ 222876A
Authority
NZ
New Zealand
Prior art keywords
dopamine
intermediates
beta
hydroxylase inhibitors
hydroxylase
Prior art date
Application number
NZ222876A
Other languages
English (en)
Inventor
J S Frazee
C Kaiser
L I Kruse
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of NZ222876A publication Critical patent/NZ222876A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/38One sulfur atom
    • C07D239/40One sulfur atom as doubly bound sulfur atom or as unsubstituted mercapto radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ222876A 1984-03-19 1985-03-14 Intermediates of dopamine-beta-hydroxylase inhibitors NZ222876A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59066584A 1984-03-19 1984-03-19

Publications (1)

Publication Number Publication Date
NZ222876A true NZ222876A (en) 1988-09-29

Family

ID=24363168

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ211440A NZ211440A (en) 1984-03-19 1985-03-14 Dopamine-beta-hydroxylase inhibitors and pharmaceutical compositions
NZ222876A NZ222876A (en) 1984-03-19 1985-03-14 Intermediates of dopamine-beta-hydroxylase inhibitors

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NZ211440A NZ211440A (en) 1984-03-19 1985-03-14 Dopamine-beta-hydroxylase inhibitors and pharmaceutical compositions

Country Status (9)

Country Link
KR (1) KR850006189A (xx)
DK (2) DK118985A (xx)
FI (1) FI83309C (xx)
HU (1) HU194184B (xx)
IL (1) IL74586A (xx)
NO (1) NO162616C (xx)
NZ (2) NZ211440A (xx)
PH (1) PH21032A (xx)
ZW (1) ZW4285A1 (xx)

Also Published As

Publication number Publication date
NO851056L (no) 1985-09-20
KR850006189A (ko) 1985-10-02
ZW4285A1 (en) 1985-06-26
HUT37602A (en) 1986-01-23
DK118985A (da) 1985-09-20
IL74586A0 (en) 1985-06-30
NO162616B (no) 1989-10-16
DK118985D0 (da) 1985-03-15
DK189691A (da) 1991-11-20
FI83309C (fi) 1991-06-25
NO162616C (no) 1990-01-24
NZ211440A (en) 1988-09-29
PH21032A (en) 1987-06-30
FI851073A0 (fi) 1985-03-18
DK189691D0 (da) 1991-11-20
FI851073L (fi) 1985-09-20
HU194184B (en) 1988-01-28
IL74586A (en) 1988-11-30
FI83309B (fi) 1991-03-15

Similar Documents

Publication Publication Date Title
ZA855593B (en) Use of propiophenone compound
GB8509322D0 (en) Determination of microconstituent
GB8721347D0 (en) Intermediates
PT83076A (en) Dopamine-beta-hydroxylase inhibitors
DE3565934D1 (en) Use of propiophenone compound
PT83628B (en) Dopamine-beta-hydroxylase inhibitors
GB2160289B (en) Spray-sealing of pipes
IL74630A (en) Preparation of 2-oxindole-1-carboxamides and n-chlorosulfonyl-2-oxindole-1-carboxamide intermediates therefor
PT84624A (en) Ester produgs of dopamine-beta-hydroxylase inhibitors
GB8525722D0 (en) Assembly of pipes
AU4798285A (en) Purification of nitriles
NZ222876A (en) Intermediates of dopamine-beta-hydroxylase inhibitors
PT83626A (en) Dopamine-beta-hydroxylase inhibitors
ZA86949B (en) Dopamine-beta-hydroxylase inhibitors
GB8409208D0 (en) Rapid purification of quinoproteins
ZA842963B (en) Dopamine-beta-hydroxylase inhibitors
ZA842962B (en) Dopamine-beta-hydroxylase inhibitors
GB8526818D0 (en) Operation of bioreactor
EP0175291A3 (en) Novel alpha-d-mannosidase inhibitor
JPS57190186A (en) Inhibitor for adhesion of organism
BG33355A1 (en) Inhibitors of c- amf- phosphodiestherasate
PL246376A2 (en) Method of use of inoculant
IL88084A0 (en) Intermediates to benzoylphenylureas
BG32479A1 (en) Inhibitor of c- amf- phosphodiesterase
GB2199032B (en) Eergoline derivatives useful as intermediates